Bedwetting: Guidelines for primary care
DOI:
https://doi.org/10.32385/rpmgf.v23i3.10360Keywords:
Enuresis in children, ManagementAbstract
Introduction: Nocturnal enuresis (NE) is the most common paediatric urologic problem in Primary Care (PC). The prevalence is 6% to 10% among 7-year-olds. It may significantly alter both children and their families quality of life. The family physician should be aware of the problem and should be able to manage it properly. Objectives: To review and systematize the recently published data about the management of NE in children; to define a decision algorithm and the indications to refer to Secondary Care (SC). Methods: We searched the Medline, Cochrane and Portuguese Medical Index Publications to find articles published between 2000 and 2005. Review articles, systematic reviews, clinical trials, meta-analyses, clinical guidelines and Portuguese original studies were included. Relevant articles related to the previous ones were also obtained. SORT taxonomy was used. Results: The initial management of NE requires a clinical history, a directed physical examination and urinalysis. When NE represents a problem for the child, treatment should be offered. Counselling, Information and Positive Reinforcement should be the first intervention; in the absence of positive results we can use the Alarm or Desmopressin as therapeutic options. There is clinical evidence that Alarm should be the first therapeutic option, because of its higher probability of long-term success; however, significant motivation by the child and their families is required. Although Desmopressin has a more immediate effect, it also has higher relapse rates. When monotherapy does not result, the association of Alarm with Desmopressin is also an option. Polysymptomatic NE and no therapeutic success cases should be referred to SC. Conclusion: Children with Monosymptomatic NE can be treated by their Family Physician. An evidence based clinical decision algorithm in PC is proposed.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.